PMID: 25797252Mar 24, 2015Paper

CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

Oncotarget
Shi-Lin XiaJia Liu

Abstract

Glioblastomas respond differently to all-trans retinoic acid (RA) for unknown reasons. Because CRABP-II and FABP5 mediate RA intracellular signaling respectively and lead to distinct biological consequences, their expression patterns in different grades of astrocytomas and the glioblastoma cells lines LN18, LN428 and U251 were examined to identify potential correlations with RA sensitivities. The response of glioblastoma cells to RA, decitabine or the FABP5 competitive inhibitor, BMS309403, was analyzed. CRABP-II and FABP5 were expressed to varying degrees by the 84-astrocytoma cases examined. Treatment of LN428, U251 and LN18 cells with RA failed to suppress their growth; however, U251 proliferation was inhibited by decitabine. The combination of decitabine and RA suppressed the growth of all three cell lines and induced significant apoptosis of LN428 and U251 cells. Both CRABP-II and FABP5 were transcribed in the three cell lines but FABP5 proteins were undetectable in U251 cells. The ratio of CRABP-II to FABP5 was not altered after RA, decitabine or RA and decitabine treatment and the resistance of cells to RA was not reversed by BMS309403 treatment. In conclusion, CRABP-II and FABP5 expression patterns are neither related t...Continue Reading

References

Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sutisak KitareewanEthan Dmitrovsky
Dec 10, 2003·Acta neurochirurgica·W GüntherA J A Terzis
Jun 28, 2005·Journal of Neuropathology and Experimental Neurology·Hiroko Ohgaki, Paul Kleihues
Oct 13, 2005·Annals of Hematology·Dick de Vos, Wendy van Overveld
Feb 3, 2007·Cancer Science·Daisuke KobayashiNaoki Watanabe
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Nov 3, 2007·Genes & Development·Frank B FurnariWebster K Cavenee
May 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Thaddeus T SchugNoa Noy
Jul 2, 2008·Neoplasia : an International Journal for Oncology Research·Li-Jun YuJia Liu
Jun 23, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Andrew J GaudenStanislaw J Gauden
Feb 20, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·B Tran, M A Rosenthal
Feb 25, 2011·Journal of the National Cancer Institute·Sebastian BarbusPeter Lichter
Apr 26, 2011·The American Journal of Pathology·Benito CamposChristel Herold-Mende
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Trisha R SippelAllen Waziri
Mar 22, 2012·European Archives of Psychiatry and Clinical Neuroscience·Julian Hellmann-RegenGolo Kronenberg
Apr 28, 2012·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Jing-Xin MaJia Liu
Apr 24, 2014·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Björn Hackanson, Michael Daskalakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis